NALOXONE HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order to Cardinal Health, Inc. under the basic contract SPE2DX-25-D-8022 for the procurement of Naloxone Hydrochloride Injection, with a total contract value of $1,912.56. The order, issued on July 18, 2026, specifies the delivery of two packages of the medication to the USS JOHN P MURTHA (LPD 26) at FPO AP 96694, with a required delivery date of July 20, 2026. The item is identified by NSN 6505016998878 and priced at $956.28 per package, with no variance allowed in quantity. Delivery is made on a FOB destination basis, meaning Cardinal Health assumes responsibility for shipping costs and risk until receipt at the destination, where the government conducts inspection and acceptance. The awardee is certified as a small business, a small disadvantaged business, and a women-owned business, triggering applicable federal reporting obligations under FAR 52.219-9 and SBA regulations. Packaging and marking requirements are minimal, mandating only that all packages and documents be labeled with the contract and delivery order numbers, with no reference to MIL-STD standards or specific preservation techniques. Payment will be processed by the Defense Finance and Accounting Service via remittance to P.O. Box 182317, Columbus, OH, under payment code SL4701, with invoicing likely conducted through electronic data interchange. The contracting officer is Lisa Quinn, located at DLA Troop Support in Philadelphia, though no Contracting Officer’s Representative is listed. The order includes no options, special personnel requirements, security clearances, or organizational conflict of interest provisions. Compliance with the base contract and internal DLA procedural notes C19 and C20 is required, and no external quality or technical standards beyond conformance to contract terms are specified.